L E Diamond Selected Research

bremelanotide

4/2005	Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response.
4/2004	Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.
2/2004	Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.
6/2003	PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L E Diamond Research Topics

Disease

4	Erectile Dysfunction 04/2005 - 06/2003
1	Fibrosis (Cirrhosis) 11/2000
1	Lung Diseases (Lung Disease) 07/2000
1	Liver Failure 01/2000
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2000

Drug/Important Bio-Agent (IBA)

4	bremelanotideIBA 04/2005 - 06/2003
3	MelanocortinsIBA 04/2005 - 02/2004
3	Sildenafil Citrate (Viagra)FDA Link 04/2005 - 02/2004
2	Melanocortin Receptors (Melanocortin Receptor)IBA 04/2005 - 02/2004
1	Vardenafil Dihydrochloride (Levitra)FDA Link 04/2005
1	TabletsIBA 04/2005
1	Immunoglobulin M (IgM)IBA 11/2000

Therapy/Procedure

2	Transplantation 07/2000 - 01/2000
1	Intranasal Administration 02/2004
1	Liver Transplantation 01/2000